NEOGENOMICS INC (NEO) › RevenueNEOGENOMICS INC (NEO) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $231.81M2017: $240.25M2018: $276.74M2019: $408.83M2020: $444.45M2021: $484.33M2022: $509.73M2023: $591.64M2024: $660.57M2025: $727.33M$727.33M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$727.33M+10.1%2024$660.57M+11.6%2023$591.64M+16.1%2022$509.73M+5.2%2021$484.33M+9.0%2020$444.45M+8.7%2019$408.83M+47.7%2018$276.74M+15.2%2017$240.25M+3.6%2016$231.81M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share